CN Stock MarketDetailed Quotes

300759 Pharmaron Beijing

Watchlist

25.30
+3.01+13.50%

Market Closed Sep 27 15:00 CST

45.22BMarket Cap23.45P/E (TTM)

Pharmaron Beijing Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharmaron Beijing Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 3.672B	--
--	2024/Q3	-- / 3.442B	--
--	2024/Q2	2.934B / 3.196B	--
--	2024/Q1	2.671B / 2.883B	--
--	2023/Q4	2.978B / 2.937B	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 3.672B--

--2024/Q3-- / 3.442B--

--2024/Q22.934B / 3.196B--

--2024/Q12.671B / 2.883B--

--2023/Q42.978B / 2.937B--

Unlock Free Earnings Estimates

Open Account

Pharmaron Beijing Earnings Reports

Kanglong Chemical: 2024 Semi-Annual Report

Aug 27 12:00 ET

Kanglong Chemical: 2024 Semi-Annual Report Summary

Aug 27 12:00 ET

Pharmaron Beijing: 2024 Interim Performance Forecast

Jul 21 12:00 ET

Pharmaron Beijing: 2024 First Quarter Report

Apr 25 12:00 ET

Analyst Rating

Updated: Sep 28, 2024

Strong Buy

Strong Buy
78.95%
Buy
15.79%
Hold
5.26%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall